Olympus Corporation: Transfer of Orthopedic Surgery Business
Nishimura & Asahi advised Olympus Corporation [TSE: 7733] on the transfer of its orthopedic surgery business in Japan and France to Polaris Capital Group Co., Ltd.
The Nishimura & Asahi team advising Olympus was led by partners Takahiko Date, Jiro Abe, Yoshiyuki Kizu, Yoko Kasai, Masanori Kaneko and Hudson Hamilton.
People
Yoshi’s practice covers various M&A transactions, cross border deals, and day-to-day commercial businesses, with a focus on Europe-related matters. He lived in Europe approx. 8 years including studying at the master of law at UCL in London, working approx. 3 years in leading firms in Frankfurt, Paris and Italy, a short secondment in Barcelona/Madrid and having regular business trips all across Europe including the Netherlands, Nordic countries and Eastern Europe. As a leading partner of Europe practice and cross-border team, Yoshi provides a tailored legal services in a timely and flexible manner.
Yoko KASAI
- Partner
- Tokyo
Yoko’s practice focuses on representation of life sciences and technology companies that develop and market pharmaceuticals, biologics, vaccines, diagnostics, medical devices, and digital health products. She specializes in corporate transactions involving complex intellectual property and pharmaceutical regulatory issues, including mergers and acquisitions, joint ventures, strategic alliances and asset transfers. In addition, she counsels clients on matters involving research and development collaborations, clinical trials, technology licensing, supply and distribution agreements, and co-promotion arrangements. She also advises clients in connection with privacy and personal data protection matters.
Masanori handles a wide-range of corporate law matters, such as M&A, responses to shareholder activists, organizational restructuring, corporate governance, disputes, crisis management, and general corporate (including labor matters). With respect to M&A transactions, he is engaged in both domestic and overseas projects, covering a range of organizations including listed and unlisted companies, and investment funds. He is a skilled communicator and dedicated to ensuring that his clients are kept well-informed and receive practical and effective advice.
Hudson regularly advises Japanese and non-Japanese clients in large, complex cross-border transactions, including stock acquisitions, asset acquisitions, private equity and venture capital investments, intellectual property agreements, joint ventures and strategic alliances. Clients value his communication skills, both in Japanese and English, and his dedication to producing successful outcomes.
Takahiko handles a wide range of domestic and international M&A transactions, general corporate matters, and labor matters. In particular, he has extensive experience in private equity fund investments, cross-border transactions (mainly in Europe and the U.S.), as well as TMT and pharmaceutical industry-related M&A transactions. Regardless of the difficulty or complexity of a case, his policy is to respond in a flexible, appropriate, and timely manner in accordance with his clients’ needs and expectations. He is also actively involved in D&I activities and pro bono work.